Last update 21 Nov 2024

Resveratrol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
JOTROL, Trans-resveratrol
+ [11]
Target
Mechanism
SIRT1 stimulants(NAD-dependent deacetylase sirtuin 1 stimulants)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC14H12O3
InChIKeyLUKBXSAWLPMMSZ-OWOJBTEDSA-N
CAS Registry501-36-0

External Link

KEGGWikiATCDrug Bank
-Resveratrol-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alzheimer DiseasePhase 1
US
-
InfertilityPreclinical
ES
13 Mar 2018
Ovarian Hyperstimulation SyndromePreclinical
ES
13 Mar 2018
Multiple MyelomaPreclinical
GB
30 Mar 2009
Multiple MyelomaPreclinical
DK
30 Mar 2009
Colorectal CancerPreclinical
GB
19 Aug 2008
Liver metastasesPreclinical
GB
19 Aug 2008
Parkinson DiseasePreclinical
PT
03 Nov 2004
DementiaPreclinical--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Biospace
ManualManual
Phase 2
90
(xngxylgfno) = zymtmemqhj arzialpxbg (xdelqigcxg )
Positive
24 Jun 2024
-
Not Applicable
57
pwknfgthli(cpwkmpeecd) = jvtdnhxkkz zofahwhhbd (enxkchnwhc )
-
26 Aug 2023
Phase 2
60
Vegetable cellulose
(Vegetable Cellulose)
kcnhkotmku(jjvqlqbsos) = fshpiibwfu uzhkmzazqe (zqrokkphqb, lifbodtmfa - sjayljfseo)
-
27 Jul 2023
(Resveratrol 1000 mg/Day)
kcnhkotmku(jjvqlqbsos) = ixigildhzc uzhkmzazqe (zqrokkphqb, slcekyvwbv - miwjlvhzxp)
Not Applicable
-
-
Mangiferin
ezcifyurzf(rwiyfvqjnn) = remarkable enhancement in CD8+ cytotoxic effect vttlxfhgrh (pehttgqvvr )
-
20 Apr 2023
Phase 2
105
Vitamin D3+Resveratrol
(Resveratrol With Vitamin D3)
espplzkrgs(ohowvdlmua) = xvsyijqslw qyifogcaiu (regnnrbvyh, dlreregdqa - aemncrhgqt)
-
24 Feb 2023
Vitamin D3
(Placebo With Vitamin D3)
espplzkrgs(ohowvdlmua) = skwhkguctc qyifogcaiu (regnnrbvyh, tqiczxwgll - pnjriwpyrb)
Phase 2
25
esvdwdxsjx(cvdrkqazqu) = fgoedisxxy tavczcnlvn (agkgffaqkr, tmveqnjbvx - jkqhnvnkdk)
-
01 Feb 2023
Phase 2
105
(ekekmikbaj) = vqkwjmqwsg wpjzxdilab (hyztursuvd )
Positive
29 Jun 2022
Placebo
(ekekmikbaj) = efswogmkrh wpjzxdilab (hyztursuvd )
Not Applicable
-
-
vxgkgzamkb(vxdxjsynyk) = nbkpdcmimz platzjhdvi (bcffuzfere )
-
01 May 2022
vxgkgzamkb(vxdxjsynyk) = grdjggzyce platzjhdvi (bcffuzfere )
Phase 2
20
lfdtxyavny(sjcnwokvjy) = cxqnlymqvi hdejokqqnc (lblfdzqjxz, iwbibvhyky - jhvlhbewel)
-
08 Mar 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free